ATE127341T1 - Neue verwendung von modafinil. - Google Patents

Neue verwendung von modafinil.

Info

Publication number
ATE127341T1
ATE127341T1 AT91401563T AT91401563T ATE127341T1 AT E127341 T1 ATE127341 T1 AT E127341T1 AT 91401563 T AT91401563 T AT 91401563T AT 91401563 T AT91401563 T AT 91401563T AT E127341 T1 ATE127341 T1 AT E127341T1
Authority
AT
Austria
Prior art keywords
modafinil
new use
new
medicament
manufacture
Prior art date
Application number
AT91401563T
Other languages
English (en)
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of ATE127341T1 publication Critical patent/ATE127341T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Networks Using Active Elements (AREA)
  • Steroid Compounds (AREA)
AT91401563T 1990-06-14 1991-06-12 Neue verwendung von modafinil. ATE127341T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007442A FR2663225B1 (fr) 1990-06-14 1990-06-14 Nouvelle utilisation du modafinil.

Publications (1)

Publication Number Publication Date
ATE127341T1 true ATE127341T1 (de) 1995-09-15

Family

ID=9397614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91401563T ATE127341T1 (de) 1990-06-14 1991-06-12 Neue verwendung von modafinil.

Country Status (12)

Country Link
US (1) US5180745A (de)
EP (1) EP0462004B1 (de)
JP (1) JP2531868B2 (de)
KR (1) KR100190454B1 (de)
AT (1) ATE127341T1 (de)
AU (1) AU655769B2 (de)
DE (1) DE69112717T2 (de)
DK (1) DK0462004T3 (de)
FR (1) FR2663225B1 (de)
HK (1) HK1007415A1 (de)
HU (1) HU215590B (de)
TW (1) TW206916B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950010400B1 (ko) * 1990-08-16 1995-09-16 삼성전자주식회사 김치냉장고의 발효 및 저장제어방법
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (de) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
KR980010274A (ko) * 1996-07-23 1998-04-30 오상수 열전소자를 이용한 식품저장고
US6346548B1 (en) 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
KR100350444B1 (ko) * 2000-02-22 2002-08-28 만도공조 주식회사 복합형 김치저장고
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
CA2425338C (en) * 2000-10-11 2010-04-20 Cephalon, Inc. Compositions comprising modafinil compounds
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
KR100911779B1 (ko) * 2001-05-25 2009-08-12 세파론, 인코포레이티드 모다피닐을 포함하는 고형 제약 제제
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
CN1753867A (zh) * 2003-02-24 2006-03-29 马林克罗特公司 制备二苯甲基硫代乙酰胺的方法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (de) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituierte Arylmethansulfinyl-Derivate
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2238973A1 (de) 2009-04-07 2010-10-13 Cephalon France Lyophilisierte Präparate von Proteasominhibitoren
EP3854409A1 (de) 2013-08-30 2021-07-28 Green Cross Wellbeing Corporation Zusammensetzung mit verarbeitetem ginseng-pulver oder verarbeitetem ginseng-extrakt mit erhöhtem gehalt des ginsenosidbestandteils zur vorbeugung und behandlung von krebsbedingter fatigue

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520812A (en) * 1975-10-02 1978-08-09 Lafon Labor Benzhydrylsulphinyl derivatives
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
JP2531868B2 (ja) 1996-09-04
US5180745A (en) 1993-01-19
FR2663225B1 (fr) 1994-11-04
HU215590B (hu) 1999-01-28
AU7843691A (en) 1991-12-19
DE69112717T2 (de) 1996-04-11
DK0462004T3 (da) 1995-10-16
DE69112717D1 (de) 1995-10-12
JPH04230214A (ja) 1992-08-19
FR2663225A1 (fr) 1991-12-20
EP0462004A3 (en) 1992-01-22
TW206916B (de) 1993-06-01
HU911968D0 (en) 1991-12-30
EP0462004A2 (de) 1991-12-18
KR920000315A (ko) 1992-01-29
AU655769B2 (en) 1995-01-12
HUT57984A (en) 1992-01-28
HK1007415A1 (en) 1999-04-09
EP0462004B1 (de) 1995-09-06
KR100190454B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
DE69112717D1 (de) Neue Verwendung von Modafinil.
DE69232665D1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
DK0893434T3 (da) Mellemprodukter til fremstilling af oximethere
DE69528730D1 (de) Herstellung von Schwefelenthaltenden Organosiliziumverbindungen
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
ATE193839T1 (de) Reinigung von proteinen
DE69319692D1 (de) Superfluoreszierende Quelle
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
DE69119539D1 (de) Ersetzung von Hauptleitungen
DE69118428D1 (de) Prozess zur Herstellung von Polyarylensulfiden
DE68909432D1 (de) Direkte fixierung von geflochtenen strukturen.
DE69301977D1 (de) Superfluoreszierende Quelle
FI913817A7 (fi) HIV:tä neutraloivan päädeterminantin uusia suoritusmuotoja
FI930897L (fi) Protein zp3 av ytterskiktet av maenniskans aeggcell
DE69225429D1 (de) Herstellung von Dihydrocarbylpolysulfiden
NO903303D0 (no) Fremgangsmaate for syntese av alfa-hydroksyketoner.
IT9020144A0 (it) Composizione farmaceutica contenente egf
DE69107164D1 (de) Synthesis von Ethylamine.
DE69104829D1 (de) Herstellung von reibbelägen.
FI930411A0 (fi) Bombesin antagonister
DE59104744D1 (de) Neue härtbare Zusammensetzungen.
FI931669A0 (fi) Foerfarande foer framstaellning av i form gjutna skodon av olika bredd
DE59106844D1 (de) Fotochemische Herstellung von Halogenverbindungen.
DE69012441D1 (de) Herstellung von Belichtungsmasken.
AR219984A1 (es) Procedimiento mejorado para la produccion de resina abs que tiene color sustancialmente blanco

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time